accur
molecular
diagnosi
viral
pathogen
highli
depend
preanalyt
procedur
effici
two
viral
rna
extract
method
liquid
phase
partit
silicabas
adsorpt
chromatographi
effect
handl
storag
stabil
rna
isol
dengu
viru
denv
studi
viral
rna
extract
spike
sera
clinic
sampl
character
denv
infect
quantifi
taqman
realtim
pcr
presenc
high
serum
protein
sever
affect
recoveri
denv
rna
liquid
phase
partit
silicabas
method
recoveri
trizol
liquid
phase
partit
method
significantli
improv
concomit
addit
coprecipit
reduct
sera
protein
result
recoveri
similar
silicabas
method
repeat
freezethaw
cycl
affect
recoveri
viral
rna
intact
denv
found
stabl
serum
hour
recoveri
viral
rna
sera
store
lysi
bind
buffer
stabl
day
data
indic
choic
viral
rna
extract
method
condit
handl
store
clinic
sera
critic
affect
quantif
viral
nucleic
acid
clinic
sampl
impact
accuraci
reproduc
denv
diagnosi
pcrbase
assay
dengu
viru
denv
emerg
import
vectorborn
viral
diseas
usual
afflict
rural
area
endem
countri
pose
tremend
health
problem
region
organ
recommend
augment
activ
accur
laboratorybas
surveil
earli
report
dengu
viru
infect
public
health
author
preanalyt
variabl
includ
storag
transport
patient
sampl
stabil
viral
rna
sampl
method
isol
viral
rna
high
yield
qualiti
major
impact
develop
perform
success
molecular
diagnost
henc
technic
challeng
associ
preanalyt
issu
must
first
identifi
optim
variou
commerci
avail
viral
rna
extract
method
current
use
clinic
diagnost
viral
diseas
extract
kit
gener
base
two
methodsliquid
phase
partit
eg
trizol
ls
silicabas
nucleic
acid
adsorpt
chromatographi
eg
high
pure
viral
rna
qiaamp
viral
rna
kit
recoveri
viral
rna
two
method
differ
substanti
differ
virus
thu
make
choic
particular
method
isol
viral
rna
uncertain
sever
studi
isol
stabil
virus
report
focus
systemat
evalu
stabil
recoveri
denv
rna
sera
studi
examin
contribut
variou
preanalyt
variabl
sensit
denv
rna
detect
serum
use
revers
transcript
quantit
realtim
pcr
rtqpcr
critic
preanalyt
variabl
includ
perform
commerci
avail
liquid
phase
partit
silicabas
viral
rna
extract
method
effect
storag
handl
freez
thaw
stabil
denv
rna
serum
investig
strain
singapor
strain
ngc
strain
singapor
strain
singapor
propag
mosquito
cell
titer
cell
describ
except
dengu
viru
obtain
singapor
gener
hospit
singapor
cell
line
use
studi
obtain
american
type
cultur
collect
atcc
va
clinic
serum
sampl
use
studi
obtain
deidentifi
confirm
dengu
case
dengu
outbreak
malaysia
brief
confirm
dengu
case
identifi
serolog
igmcaptur
enzymelink
immunosorb
assay
panbio
australia
viru
isol
subsequ
molecular
detect
denv
genom
revers
transcriptionpcr
use
acut
serum
sampl
acut
serum
sampl
store
use
serum
specimen
patient
laboratoryconfirm
dengu
infect
use
studi
normal
human
serum
clot
human
whole
blood
human
serum
albumin
hsa
obtain
sigmaaldrich
st
loui
mo
studi
approv
nation
univers
singapor
institut
review
board
rna
extract
stabil
studi
perform
viral
rna
extract
trizol
ls
invitrogen
ca
presenc
absenc
linear
acrylamid
gml
ambion
tx
coprecipit
high
pure
viral
rna
isol
kit
roch
appli
scienc
germani
qiaamp
viral
rna
kit
qiagen
germani
briefli
physiolog
relev
titrat
concentr
denv
virion
plaqu
form
unit
pfu
ml
genom
rna
copiesml
ad
commerci
avail
normal
human
sera
pb
premix
lysisbind
buffer
prevent
viral
rna
degrad
extract
extract
perform
accord
respect
manufactur
protocol
control
total
viral
rna
amount
denv
directli
lyse
presenc
rnasin
ribonucleas
inhibitor
promega
wi
heat
minut
rtqpcr
studi
rna
stabil
human
serum
genom
rna
virion
spike
human
serum
incub
studi
stabil
viral
rna
lysisbind
buffer
denvspik
normal
human
sera
ad
roch
high
pure
viral
rna
isol
lysisbind
buffer
kept
freezethaw
studi
normal
human
sera
spike
denv
patient
sera
frozen
thaw
temperaturecontrol
water
bath
freezethaw
cycl
repeat
recoveri
viral
rna
extract
calcul
use
formula
c
recov
rna
c
control
rna
amplif
effici
effici
extract
variables
singlestrand
rna
use
silicabas
extract
method
evalu
use
experion
autom
electrophoresi
system
biorad
ca
accord
manufactur
instruct
serotypespecif
primer
fluorogen
probe
design
use
beacon
design
version
premier
biosoft
intern
ca
vector
nti
version
invitrogen
ca
softwar
serotyp
specif
primer
evalu
comparison
avail
publish
sequenc
complet
genom
follow
comparison
specif
region
use
combin
pandenv
align
analys
blast
search
probe
label
end
hex
report
dye
end
black
hole
quencher
probe
label
texa
red
tabl
perform
primerprob
set
determin
use
vitro
transcrib
genom
viral
rna
assay
dynam
rang
detect
greater
fold
detect
limit
copiesreact
serotyp
specif
assay
greater
fold
detect
heterolog
denv
serotyp
rtqpcr
perform
onestep
taqman
rna
amplif
kit
roch
molecular
system
nj
use
mmoll
mn
moll
primer
moll
taqman
probe
biorad
multicolor
realtim
icycl
biorad
laboratori
ca
sens
antisens
primer
denot
suffix
f
r
respect
taqman
probe
denot
suffix
p
genom
posit
defin
accord
genbank
access
number
anwar
et
al
jmd
novemb
vol
follow
condit
minut
amperas
step
minut
denatur
minut
revers
transcript
follow
cycl
second
denatur
second
anneal
second
extens
viral
rna
copi
number
interpol
standard
curv
gener
use
vitro
transcrib
genom
rna
use
megascript
transcript
kit
ambion
tx
accord
manufactur
instruct
sequenc
primer
probe
use
taqman
assay
shown
tabl
experi
done
quadrupl
assay
duplic
studi
perform
two
independ
oper
cumul
result
analyz
statist
analys
perform
use
graphpad
prism
softwar
graphpad
prism
softwar
inc
ca
intraassay
imprecis
perform
determin
withinrun
total
standard
deviat
calcul
c
valu
replic
sampl
low
l
reaction
volum
high
l
reaction
volum
concentr
viral
rna
interassay
imprecis
similarli
calcul
c
valu
collect
period
consecut
day
lot
reagent
extract
rna
sera
contain
differ
amount
viral
genom
rna
titer
denv
trizol
ls
absenc
linear
acrylamid
found
ineffici
control
rna
compar
recoveri
virusspik
pb
sampl
control
rna
figur
inclus
linear
acrylamid
sera
howev
significantli
improv
recoveri
viral
rna
figur
test
hypothesi
serum
protein
contribut
poor
recoveri
rna
denv
viral
genom
rna
spike
vari
dilut
serum
differ
amount
hsa
extract
perform
use
trizol
ls
linear
acrylamid
result
indic
invers
linear
relationship
recoveri
rna
increas
sera
protein
concentr
denv
r
sera
hsa
respect
figur
viral
genom
rna
r
consist
previou
report
pfu
significantli
lower
rna
copi
number
next
explor
use
silica
filterbas
adsorpt
nucleic
acid
extract
viral
rna
biolog
fluid
recoveri
rna
denv
viral
genom
rna
sampl
compar
two
silicabas
kit
assess
effici
compar
control
figur
b
remark
silicabas
method
show
preferenti
bind
higher
molecular
mass
rna
also
effici
recov
small
rna
kb
figur
ac
recoveri
rna
serum
howev
found
statist
lower
figur
compar
extract
pb
consist
result
asterisk
denot
statist
signific
tukey
test
p
p
amount
viral
rna
recov
compar
control
rna
c
viral
rna
isol
either
viru
pfuml
genom
rna
copiesml
use
trizol
ls
reagent
linear
acrylamid
addit
presenc
vari
dilut
normal
human
serum
mgml
total
protein
human
serum
albumin
hsa
asterisk
denot
statist
signific
pair
student
ttest
p
amount
viral
rna
recov
sampl
high
protein
content
mgml
compar
control
rna
isol
viral
rna
assay
use
roch
taqman
rna
amplif
kit
parallel
genom
viral
rna
standard
control
refer
amount
viral
rna
obtain
direct
lysi
method
experi
perform
quadrupl
assay
duplic
data
express
mean
sem
effect
sera
protein
figur
extract
studi
describ
also
perform
similar
result
obtain
data
shown
pcr
may
inhibit
chemic
copurifi
extract
control
studi
use
exogen
transcript
presenc
serum
pb
perform
rtqpcr
green
fluoresc
protein
rna
copiesml
affect
eluat
produc
variou
extract
procedur
reagent
use
data
shown
comparison
liquid
phase
partit
silicabas
method
next
perform
thirteen
retrospect
patient
sera
viral
rna
isol
use
either
trizol
ls
linear
acrylamid
high
pure
viral
rna
kit
presenc
serum
recoveri
denv
rna
trizol
ls
consist
lower
variabl
compar
silicabas
method
figur
twotail
ttest
p
patient
sera
recoveri
denv
rna
use
silicabas
method
similar
without
dilut
patient
sera
pb
figur
b
twotail
ttest
p
patient
signific
improv
recoveri
viral
rna
pbsdilut
patient
sera
use
trizol
ls
figur
b
twotail
ttest
p
sera
test
exist
cellfre
circul
cellular
viral
rna
plasma
serum
report
stabil
free
denv
rna
sera
found
exceedingli
poor
extens
loss
detect
rna
figur
howev
viru
rel
stabl
serum
longer
period
time
simplifi
sampl
handl
maintain
prolong
viral
rna
integr
extract
feasibl
use
lysisbind
buffer
extract
kit
contain
chaotrop
store
denvcontain
sampl
examin
viral
rna
isol
denvinfect
sera
kept
lysi
bind
buffer
found
stabl
least
day
figur
tukey
test
p
addit
sinc
common
patient
sera
undergo
cycl
freezethaw
retrospect
studi
effect
repeat
freezethaw
cycl
denv
rna
recoveri
integr
also
examin
unexpectedli
amount
intact
denv
rna
affect
repeat
freezethaw
cycl
figur
analysi
varianc
p
aim
studi
gain
better
insight
perform
two
wide
use
rna
extract
meth
od
virolog
diagnost
laboratori
determin
optim
condit
sampl
handl
minim
loss
denv
viral
rna
integr
liquid
phase
partitionbas
extract
accept
routin
extract
clinic
sampl
variou
viral
diseas
recommend
detect
hiv
hepat
c
viru
hepat
gb
viruschepat
g
maximum
sensit
need
howev
result
present
studi
indic
recoveri
denv
rna
sera
poor
trizol
ls
consist
report
could
significantli
improv
use
linear
acrylamid
coprecipit
reduct
serum
protein
similarli
enhanc
recoveri
viral
rna
appar
dilut
denvinfect
patient
sera
use
improv
perform
silicabas
rna
extract
method
presenc
sera
like
due
reduc
interfer
sera
protein
predominantli
serum
albumin
contrari
observ
silica
preferenti
bind
high
molecular
weight
rna
may
exclud
use
isol
small
size
rna
result
altern
viral
transcript
discontinu
extens
subgenom
viral
rna
partial
degrad
found
small
singlestrand
rna
bind
effici
preferenti
bind
higher
molecular
mass
rna
data
therefor
impli
silicabas
liquidphas
partit
method
trizol
reagent
product
insert
invitrogen
carlsbad
ca
effect
recov
variou
genom
subgenom
viral
rna
wide
rang
size
suggest
protocol
storag
denvinfect
patient
sera
recommend
world
health
organizationsearo
without
thaw
repeat
freezethaw
cycl
shown
affect
integr
cellfre
rna
viral
rna
significantli
unexpectedli
recoveri
denv
rna
found
affect
repeat
freezethaw
viru
serum
like
due
protect
effect
serum
protein
stabil
viral
particl
similar
report
previous
anoth
member
flavivirida
famili
hepat
c
viru
howev
unlik
hepat
c
viru
show
statist
signific
increas
rna
recov
progress
freezethaw
cycl
signific
chang
observ
recoveri
denv
rna
present
studi
also
show
chaotropecontain
lysisbind
buffer
could
use
store
maintain
viral
rna
integr
least
day
conclus
recommend
denv
rna
isol
use
liquid
phase
partit
method
necessari
includ
coprecipit
reduc
serum
protein
phase
partit
howev
dilut
sera
pb
viral
rna
isol
use
either
trizol
ls
presenc
linear
acrylamid
high
pure
viral
rna
isol
kit
viral
rna
quantifi
use
taqman
realtim
pcr
assay
parallel
vitro
transcrib
rna
standard
experi
done
quadrupl
assay
duplic
data
express
mean
sem
asterisk
denot
statist
signific
pair
student
ttest
p
p
sampl
handl
viral
rna
stabil
viru
pfuml
genom
rna
copiesml
ad
human
serum
incub
minut
b
viru
pfuml
serum
ad
bind
buffer
roch
high
pure
rna
isol
kit
kept
day
c
sera
pfuml
posit
patient
sera
titer
rang
copiesml
frozen
thaw
freezethaw
cycl
repeat
time
viral
rna
isol
high
pure
viral
rna
kit
quantifi
use
taqman
realtim
pcr
assay
togeth
vitro
transcrib
genom
rna
standard
percentag
recoveri
normal
nonincub
sampl
experi
done
quadrupl
assay
duplic
asterisk
denot
statist
signific
differ
tukey
test
p
data
express
mean
sem
may
help
recoveri
viral
rna
sensit
assay
low
viral
level
may
affect
distinct
advantag
use
silicabas
adsorpt
method
easili
autom
use
robot
cost
effici
conveni
maintain
optim
viral
rna
integr
sera
store
lysisbind
buffer
transport
room
temperatur
diagnost
laboratori
extract
use
silicabas
adsorpt
method
without
need
coldchain
storag
